🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 80810D103
- Market Cap
- Large Cap
- IPO
- 2/6/2020 · $17.00/share
Business: Schrödinger, Inc.'s industry-leading computational platform to accelerate drug discovery and materials design is deployed by leading biopharmaceutical and industrial companies, academic institutions and government laboratories worldwide. Schrödinger is also applying its computational platform to a robust pipeline of drug discovery programs in collaboration with pharmaceutical companies and has co-founded leading biotech companies, including Nimbus Therapeutics. In addition, Schrödinger is using its platform to advance a pipeline of internal, wholly-owned drug discovery programs.
Company Contact
- CEO
- Ramy Farid
- CFO
- Geoff Porges
- Headquarters
- 1540 Broadway, 24th Floor, New York, NY 10036
- Phone
- 212-295-5800
- Investor Relations
- Christina Tartaglia, Stern IR, Inc. · 212-362-1200 · christina.tartaglia@sternir.com